Clinical Trial Update: Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study evaluating decitabine in combination with genistein for pediatric relapsed or refractory cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Decitabine (Decitabine)
• Genistein (genistein)

Snippet

Sponsor: St. Justine's Hospital | Conditions: Cancer | Phase 1, Phase 2 | Status: COMPLETED